Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Trial record 1 of 1 for:    nic-pd
Previous Study | Return to List | Next Study

Disease-modifying Potential of Transdermal NICotine in Early Parkinson's Disease (NIC-PD)

This study is ongoing, but not recruiting participants.
Michael J. Fox Foundation for Parkinson's Research
Parkinson Study Group (PSG)
International Parkinson Fonds Germany GmbH
German Parkinson Study Group (GPS)
German Parkinson Society (DPG)
Philipps University Marburg Medical Center
Information provided by (Responsible Party):
James BOYD MD, University of Vermont Identifier:
First received: March 9, 2012
Last updated: September 28, 2015
Last verified: September 2015
No Study Results Posted on for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2016
  Estimated Primary Completion Date: August 2016 (Final data collection date for primary outcome measure)